{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:29:02Z","timestamp":1790501342311,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00201","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T04:23:13Z","timestamp":1549599793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":143,"title":["The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders"],"prefix":"10.3389","volume":"10","author":[{"given":"Silke","family":"H\u00e4usser-Kinzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40263-016-0396-6","article-title":"B cell-directed therapeutics in multiple sclerosis: rationale and clinical evidence","volume":"30","author":"Kinzel","year":"2016","journal-title":"CNS Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/400_2009_21","article-title":"Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis","volume":"51","author":"Weber","year":"2010","journal-title":"Results Probl Cell Differ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1172\/JCI28330","article-title":"Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell\/B cell cooperation","volume":"116","author":"Krishnamoorthy","year":"2006","journal-title":"J Clin Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20090299","article-title":"Spontaneous relapsing-remitting EAE in the SJL\/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells","volume":"206","author":"Pollinger","year":"2009","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","article-title":"The role of CD40 ligand in costimulation and T-cell activation","volume":"153","author":"Grewal","year":"1996","journal-title":"Immunol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4049\/jimmunol.0902206","article-title":"CD40 expression levels modulate regulatory T cells in Leishmania donovani infection","volume":"185","author":"Martin","year":"2010","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Genc","year":"1997","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458516664210","article-title":"Increased ex vivo antigen presentation profile of B cells in multiple sclerosis","volume":"23","author":"Mathias","year":"2016","journal-title":"Mult Scler"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jneuroim.2006.10.020","article-title":"Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection","volume":"183","author":"Harp","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/eji.201040516","article-title":"Memory B cells from a subset of treatment-naive relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-gamma production in response to myelin basic protein and myelin oligodendrocyte glycoprotein","volume":"40","author":"Harp","year":"2010","journal-title":"Eur J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e105421","DOI":"10.1371\/journal.pone.0105421","article-title":"A novel MicroRNA-132-Surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis","volume":"9","author":"Miyazaki","year":"2014","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1742-2094-8-146","article-title":"Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders","volume":"8","author":"Lehmann-Horn","year":"2011","journal-title":"J Neuroinflammation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI36030","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34594","DOI":"10.1038\/srep34594","article-title":"B cell-derived transforming growth factor-beta1 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjarnadottir","year":"2016","journal-title":"Sci Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1756285612474333","article-title":"Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges","volume":"6","author":"Lehmann-Horn","year":"2013","journal-title":"Ther Adv Neurol Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/ijms18102048","article-title":"Deciphering the role of B cells in multiple sclerosis\u2014towards specific targeting of pathogenic function","volume":"18","author":"Lehmann-Horn","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1586\/1744666X.2016.1152888","article-title":"The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy","volume":"12","author":"Crofford","year":"2016","journal-title":"Exp Rev Clin Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/glia.22803","article-title":"Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism","volume":"63","author":"Menzfeld","year":"2015","journal-title":"Glia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13152","DOI":"10.1073\/pnas.94.24.13152","article-title":"Btk dosage determines sensitivity to B cell antigen receptor cross-linking","volume":"94","author":"Satterthwaite","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.4049\/jimmunol.171.4.1850","article-title":"Reduced dosage of Bruton's Tyrosine Kinase Uncouples B Cell hyperresponsiveness from autoimmunity in lyn\u2212\/\u2212 mice","volume":"171","author":"Whyburn","year":"2003","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","article-title":"Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice","volume":"119","author":"Kil","year":"2012","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc Natl Acad Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00000441-195001000-00009","article-title":"A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases","volume":"219","author":"Kabat","year":"1950","journal-title":"Am J Med Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2008.12.029","article-title":"The prognostic significance of cerebrospinal fluid in multiple sclerosis","volume":"279","author":"Siritho","year":"2009","journal-title":"J Neurolog Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1714","article-title":"Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis","volume":"14","author":"Obermeier","year":"2008","journal-title":"Nat Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI3568","article-title":"Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis","volume":"102","author":"Qin","year":"1998","journal-title":"J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/brain\/awu205","article-title":"Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation","volume":"137","author":"Beltr\u00e1n","year":"2014","journal-title":"Brain"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1172\/JCI63842","article-title":"B cell exchange across the blood-brain barrier in multiple sclerosis","volume":"122","author":"Von","year":"2012","journal-title":"J Clin Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24088","article-title":"In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses","volume":"75","author":"Bankoti","year":"2014","journal-title":"Ann Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"248ra106","DOI":"10.1126\/scitranslmed.3008930","article-title":"Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis","volume":"6","author":"Palanichamy","year":"2014","journal-title":"Sci Transl Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci Transl Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/aws105","article-title":"Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis","volume":"135","author":"Elliott","year":"2012","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","article-title":"Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants","volume":"130","author":"Blauth","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/135245859800400304","article-title":"The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult Scler."},{"key":"B48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0022-510X(94)90158-9","article-title":"Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid","volume":"121","author":"Warren","year":"1994","journal-title":"J Neurol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.002","article-title":"Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis","volume":"238","author":"Brennan","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1073\/pnas.0901496106","article-title":"Contactin-2\/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals","volume":"106","author":"Derfuss","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1110740","article-title":"Potassium channel KIR4","volume":"367","author":"Srivastava","year":"2012","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult Scler J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMc1507131","article-title":"Multiple sclerosis and antibodies against KIR4","volume":"374","author":"Pr\u00f6bstel","year":"2016","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B55","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"B57","first-page":"409","article-title":"The aquaporin family of water channels in kidney","volume":"17","author":"Agre","year":"1996","journal-title":"Nephrologie"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus","year":"2013","journal-title":"Physiol Rev."},{"key":"B59","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.108.9.2993","article-title":"Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues","volume":"108","author":"Frigeri","year":"1995","journal-title":"J Cell Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamaneurol.2013.3124","article-title":"Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica","volume":"70","author":"Matiello","year":"2013","journal-title":"JAMA Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury","volume":"133","author":"Marignier","year":"2010","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-013-1220-8","article-title":"Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions","volume":"127","author":"Wrzos","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/B978-0-12-800100-4.00006-4","article-title":"Immunopathogenesis of neuromyelitis optica","volume":"121","author":"Levy","year":"2014","journal-title":"Adv Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"B68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius","year":"2010","journal-title":"J Neuroinflamm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/acn3.418","article-title":"CNS Aquaporin-4-specific B cells connect with multiple B-cell compartments in neuromyelitis optica spectrum disorder","volume":"4","author":"Kowarik","year":"2017","journal-title":"Ann Clin Transl Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype","volume":"12","author":"Probstel","year":"2015","journal-title":"J Neuroinflamm."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","article-title":"Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes","volume":"263","author":"Sepulveda","year":"2016","journal-title":"J Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1212\/NXI.0000000000000020","article-title":"MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS","volume":"1","author":"Varrin-Doyer","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1521-4141(2002010)32:10<2737::AID-IMMU2737>3.0.CO;2-0","article-title":"Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus","volume":"32","author":"Bruno","year":"2002","journal-title":"Eur J Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/NXI.0000000000000022","article-title":"Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE","volume":"1","author":"Shetty","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B76","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1352458514551455","article-title":"Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody","volume":"21","author":"Ikeda","year":"2015","journal-title":"Mult Scler."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/jnnp-2015-312676","article-title":"Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies","volume":"87","author":"Kaneko","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/WNL.0000000000002844","article-title":"Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD","volume":"87","author":"Wang","year":"2016","journal-title":"Neurology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm."},{"key":"B81","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/jamaneurol.2018.1055","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-associated central nervous system demyelination-a novel disease entity?","volume":"75","author":"Weber","year":"2018","journal-title":"JAMA Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1073\/pnas.1519608113","article-title":"Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease","volume":"113","author":"Flach","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-016-1559-8","article-title":"Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen","volume":"132","author":"Kinzel","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.4049\/jimmunol.169.10.5415","article-title":"Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs","volume":"169","author":"De Vos","year":"2002","journal-title":"J Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jneuroim.2004.12.018","article-title":"In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology","volume":"161","author":"Fabriek","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/138161212799040501","article-title":"Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects","volume":"18","author":"Weber","year":"2012","journal-title":"Curr Pharm Des."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamaneurol.2013.3510","article-title":"Therapeutic decisions in multiple sclerosis: moving beyond efficacy","volume":"70","author":"Bruck","year":"2013","journal-title":"JAMA Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J Neuroinflamm."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ana.21744","article-title":"Pathogenic CD8(+) T cells in multiple sclerosis","volume":"66","author":"Friese","year":"2009","journal-title":"Ann Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.0b013e3181c97c8f","article-title":"Multiple sclerosis immunology: the healthy immune system vs the MS immune system","volume":"74","author":"Kasper","year":"2010","journal-title":"Neurology"},{"key":"B93","first-page":"409","article-title":"Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis","volume":"38","author":"Prineas","year":"1978","journal-title":"Lab Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archneurol.2009.157","article-title":"Depletion of B lymphocytes from cerebral perivascular spaces by rituximab","volume":"66","author":"Martin Mdel","year":"2009","journal-title":"Arch Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11910-007-0036-0","article-title":"New concepts on progressive multiple sclerosis","volume":"7","author":"Lassmann","year":"2007","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J Clin Invest."},{"key":"B97","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"B99","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bpa.12180","article-title":"Increased Meningeal T and plasma cell infiltration is associated with early subpial cortical demyelination in common marmosets with experimental autoimmune encephalomyelitis","volume":"25","author":"Kramann","year":"2015","journal-title":"Brain Pathol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J Neuroimmunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti\u2013IL-6 receptor antibody tocilizumab in neuromyelitis optica. A pilot study","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T15:53:27Z","timestamp":1662911607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2019.00201"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00201","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"article-number":"201"}}